Join
Live feed
·
PRReleasevia Quantisnow
ImmunoPrecise Antibodies Ltd. logo

AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.

ByQuantisnow·Wall Street's wire, on your screen.
IPA· ImmunoPrecise Antibodies Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPA (ImmunoPrecise Antibodies Ltd.) and more on Quantisnow.